Table 2 Study design and allocation to treatment of safety population (= Intent to Treat Population, ITT) and efficacy population (= Per Protocol Population, PP)
Dog study | |||
|---|---|---|---|
Group | Randomised as | Observation days | |
tick patients | flea patients | ||
"Imidacloprid and Flumethrin" (IVP) | 139 (114) | 132 (83) | Day 0 |
Dimpylat (CP) | 63 (52) | 66 (42) | Day 2 (+1) |
Total evaluated | 400 (291) | Day 28 (± 2) | |
Day 56 (± 2) | |||
Day 84 (± 2) | |||
Day 112 (± 2) | |||
Day 140 (± 2) | |||
Day 168 (± 2) | |||
Day 196 (± 2) | |||
Day 224 (± 2) | |||
Day 238 (± 2) | |||
Cat Study | |||
Imidacloprid/Flumethrin (IVP) Dimpylat (CP) | 159 (62) | 73 (56) | Day 0 |
52 (21) | 29 (27) | Day 2 (+1) | |
Day 28 (± 2) | |||
Day 56 (± 2) | |||
Day 84 (± 2) | |||
Day 112 (± 2) | |||
Day 140 (± 2) | |||
Day 168 (± 2) | |||
Day 196 (± 2) | |||
Day 224 (± 2) | |||
Day 238 (± 2) | |||
Total cats evaluated | 313 (166) | ||